- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/78 - Thyroid gland hormones
Patent holdings for IPC class G01N 33/78
Total number of patents in this class: 123
10-year publication summary
14
|
11
|
8
|
8
|
9
|
12
|
5
|
8
|
11
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Quest Diagnostics Investments Incorporated | 409 |
14 |
Morehouse School of Medicine | 152 |
6 |
Siemens Healthcare Diagnostics Inc. | 2040 |
6 |
Roche Diagnostics Operations, Inc. | 1471 |
4 |
F. Hoffmann-La Roche AG | 7912 |
3 |
Abbott Laboratories | 2416 |
3 |
Bio-Rad Laboratories, Inc. | 1608 |
3 |
I-calq, LLC | 12 |
3 |
Immundiagnostik AG | 129 |
3 |
Roche Diagnostics GmbH | 2687 |
2 |
Arizona Board of Regents on Behalf of Northern Arizona University | 164 |
2 |
Fujirebio Inc. | 190 |
2 |
Georgetown University | 596 |
2 |
Laboratory Corporation of America Holdings | 818 |
2 |
Ortho-Clinical Diagnostics, Inc. | 252 |
2 |
Regents of the University of Minnesota | 2684 |
2 |
University Health Network | 1020 |
2 |
Ustav Organicke Chemie a Biochemie Akademie Ved CR, V.v.i. | 14 |
2 |
Aegirbio AB | 19 |
2 |
DiaSorin Italia S.p.A | 40 |
2 |
Other owners | 56 |